Accenture Collaborates With 1910 Genetics To Help Biopharma Companies Transform Drug Discovery With AI
Acn) has invested, through accenture ventures , in 1910 genetics (or “1910”), a biotechnology company advancing small and large molecule drug. Accenture collaborates with 1910 genetics to help biopharma companies transform drug discovery with ai. Acn) has invested, through accenture ventures, in 1910 genetics (or 1910), a biotechnology company. Manish kumar november 1, 2024. Accenture invests in 1910 genetics to bolster drug discovery.
Acn) has invested, through accenture ventures, in 1910 genetics (or “1910”), a.
drug biopharma